{"id":"https://openalex.org/W3130267604","doi":"https://doi.org/10.1182/blood.2020007303","title":"BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia","display_name":"BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia","publication_year":2021,"publication_date":"2021-02-20","ids":{"openalex":"https://openalex.org/W3130267604","doi":"https://doi.org/10.1182/blood.2020007303","mag":"3130267604","pmid":"https://pubmed.ncbi.nlm.nih.gov/33598678"},"language":"en","primary_location":{"id":"doi:10.1182/blood.2020007303","doi":"https://doi.org/10.1182/blood.2020007303","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.2020007303","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/2078.1/261896","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045486705","display_name":"Charles Herbaux","orcid":"https://orcid.org/0000-0003-4910-476X","observed_orcids":["https://orcid.org/0000-0003-4910-476X"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4387152542","display_name":"Centre de Recherches en Canc\u00e9rologie de Lille","ror":"https://ror.org/05x9zmx47","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I2800921988","https://openalex.org/I3018718406","https://openalex.org/I4210131356","https://openalex.org/I4210141925","https://openalex.org/I4387152542"]}],"countries":["FR","US"],"is_corresponding":true,"raw_author_name":"Charles Herbaux","raw_affiliation_strings":["Department of Blood Diseases, Centre Hospitalier Universit\u00e9 (CHU) de Lille, Lille, France;","Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;","\u201cCANcer Heterogeneity, Plasticity and Resistance to THERapies (CANTHER),\u201d INSERM 1277, Centre National de la Recherche Scientifique (CNRS) 9020, Unit\u00e9 Mixte de Recherche en Sant\u00e9 (UMRS) 12, University of Lille, Lille, France;"],"raw_orcid":"https://orcid.org/0000-0003-4910-476X","affiliations":[{"raw_affiliation_string":"Department of Blood Diseases, Centre Hospitalier Universit\u00e9 (CHU) de Lille, Lille, France;","institution_ids":["https://openalex.org/I3018718406"]},{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"\u201cCANcer Heterogeneity, Plasticity and Resistance to THERapies (CANTHER),\u201d INSERM 1277, Centre National de la Recherche Scientifique (CNRS) 9020, Unit\u00e9 Mixte de Recherche en Sant\u00e9 (UMRS) 12, University of Lille, Lille, France;","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I4387152542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009837774","display_name":"Christoph Kornauth","orcid":"https://orcid.org/0000-0003-0443-3498","observed_orcids":["https://orcid.org/0000-0003-0443-3498"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":true,"raw_author_name":"Christoph Kornauth","raw_affiliation_strings":["Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria;","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012731491","display_name":"St\u00e9phanie Poulain","orcid":"https://orcid.org/0000-0002-1792-7270","observed_orcids":["https://orcid.org/0000-0002-1792-7270"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4387152542","display_name":"Centre de Recherches en Canc\u00e9rologie de Lille","ror":"https://ror.org/05x9zmx47","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I2800921988","https://openalex.org/I3018718406","https://openalex.org/I4210131356","https://openalex.org/I4210141925","https://openalex.org/I4387152542"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"St\u00e9phanie Poulain","raw_affiliation_strings":["Hematology Laboratory, Biology and Pathology Center, CHU de Lille, Lille, France;","\u201cCANcer Heterogeneity, Plasticity and Resistance to THERapies (CANTHER),\u201d INSERM 1277, Centre National de la Recherche Scientifique (CNRS) 9020, Unit\u00e9 Mixte de Recherche en Sant\u00e9 (UMRS) 12, University of Lille, Lille, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Laboratory, Biology and Pathology Center, CHU de Lille, Lille, France;","institution_ids":["https://openalex.org/I3018718406"]},{"raw_affiliation_string":"\u201cCANcer Heterogeneity, Plasticity and Resistance to THERapies (CANTHER),\u201d INSERM 1277, Centre National de la Recherche Scientifique (CNRS) 9020, Unit\u00e9 Mixte de Recherche en Sant\u00e9 (UMRS) 12, University of Lille, Lille, France;","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I4387152542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063159222","display_name":"Stephen Jun Fei Chong","orcid":"https://orcid.org/0000-0002-9188-7131","observed_orcids":["https://orcid.org/0000-0002-9188-7131"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen J. F. Chong","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038876039","display_name":"Mary C. Collins","orcid":"https://orcid.org/0000-0003-4282-9020","observed_orcids":["https://orcid.org/0000-0003-4282-9020"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary C. Collins","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000327956","display_name":"Rebecca Valentin","orcid":"https://orcid.org/0000-0001-8339-0902","observed_orcids":["https://orcid.org/0000-0001-8339-0902"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca Valentin","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":"https://orcid.org/0000-0001-8339-0902","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018834596","display_name":"Liam R. Hackett","orcid":"https://orcid.org/0000-0002-3330-2369","observed_orcids":["https://orcid.org/0000-0002-3330-2369"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liam Hackett","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052071966","display_name":"Olivier Tournilhac","orcid":"https://orcid.org/0000-0002-9438-621X","observed_orcids":["https://orcid.org/0000-0002-9438-621X"]},"institutions":[{"id":"https://openalex.org/I198244214","display_name":"Universit\u00e9 Clermont Auvergne","ror":"https://ror.org/01a8ajp46","country_code":"FR","type":"education","lineage":["https://openalex.org/I198244214"]},{"id":"https://openalex.org/I4405256289","display_name":"Clonal Heterogeneity, Leukemic environment, ThErapy Resistance of chronic leukemias","ror":"https://ror.org/0402qmp47","country_code":"FR","type":"facility","lineage":["https://openalex.org/I198244214","https://openalex.org/I4405256289"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Olivier Tournilhac","raw_affiliation_strings":["Clonal Heterogeneity and Leukemic Environment in Therapy Resistance of Chronic Leukemias (CHELTER), Department of Clinical Hematology and Cellular Therapy, CHU, EA7453, Universit\u00e9 Clermont Auvergne, Clermont Ferrand, France;"],"raw_orcid":"https://orcid.org/0000-0002-9438-621X","affiliations":[{"raw_affiliation_string":"Clonal Heterogeneity and Leukemic Environment in Therapy Resistance of Chronic Leukemias (CHELTER), Department of Clinical Hematology and Cellular Therapy, CHU, EA7453, Universit\u00e9 Clermont Auvergne, Clermont Ferrand, France;","institution_ids":["https://openalex.org/I198244214","https://openalex.org/I4405256289"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037590260","display_name":"Fran\u00e7ois Lemonnier","orcid":"https://orcid.org/0000-0001-6205-5419","observed_orcids":["https://orcid.org/0000-0001-6205-5419"]},"institutions":[{"id":"https://openalex.org/I3019246885","display_name":"Centre Hospitalier Universitaire Henri-Mondor","ror":"https://ror.org/04m61mj84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019246885"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210130325","display_name":"H\u00f4pitaux Universitaires Henri-Mondor","ror":"https://ror.org/033yb0967","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210130325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fran\u00e7ois Lemonnier","raw_affiliation_strings":["Lymphoid Malignancies Unit, Henri Mondor University Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Cr\u00e9teil, France;"],"raw_orcid":"https://orcid.org/0000-0001-6205-5419","affiliations":[{"raw_affiliation_string":"Lymphoid Malignancies Unit, Henri Mondor University Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Cr\u00e9teil, France;","institution_ids":["https://openalex.org/I3019246885","https://openalex.org/I4210097159","https://openalex.org/I4210130325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007139107","display_name":"Jehan Dupuis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019246885","display_name":"Centre Hospitalier Universitaire Henri-Mondor","ror":"https://ror.org/04m61mj84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019246885"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210130325","display_name":"H\u00f4pitaux Universitaires Henri-Mondor","ror":"https://ror.org/033yb0967","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210130325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jehan Dupuis","raw_affiliation_strings":["Lymphoid Malignancies Unit, Henri Mondor University Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Cr\u00e9teil, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lymphoid Malignancies Unit, Henri Mondor University Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Cr\u00e9teil, France;","institution_ids":["https://openalex.org/I3019246885","https://openalex.org/I4210097159","https://openalex.org/I4210130325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026917338","display_name":"Adrien Daniel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Adrien Daniel","raw_affiliation_strings":["Department of Blood Diseases, Centre Hospitalier Universit\u00e9 (CHU) de Lille, Lille, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Blood Diseases, Centre Hospitalier Universit\u00e9 (CHU) de Lille, Lille, France;","institution_ids":["https://openalex.org/I3018718406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022308801","display_name":"C\u00e9cile Tomowiak","orcid":"https://orcid.org/0000-0003-4093-6463","observed_orcids":["https://orcid.org/0000-0003-4093-6463"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210111187","display_name":"Centre Hospitalier Universitaire de Poitiers","ror":"https://ror.org/029s6hd13","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210111187"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Cecile Tomowiak","raw_affiliation_strings":["Hematology, Poitiers University Hospital, INSERM Clinical Investigation Center (CIC) 1402, Poitiers, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, Poitiers University Hospital, INSERM Clinical Investigation Center (CIC) 1402, Poitiers, France;","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210111187"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013996935","display_name":"Kamel Laribi","orcid":"https://orcid.org/0000-0002-4389-6164","observed_orcids":["https://orcid.org/0000-0002-4389-6164","https://orcid.org/0000-0001-5589-7570","https://orcid.org/0009-0004-8177-7870"]},"institutions":[{"id":"https://openalex.org/I4210125982","display_name":"Centre Hospitalier du Mans","ror":"https://ror.org/03bf2nz41","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210125982"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Kamel Laribi","raw_affiliation_strings":["Department of Hematology, Centre Hospitalier Du Mans, Le Mans, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Centre Hospitalier Du Mans, Le Mans, France;","institution_ids":["https://openalex.org/I4210125982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069345610","display_name":"Lo\u00efc Renaud","orcid":"https://orcid.org/0000-0001-7213-9464","observed_orcids":["https://orcid.org/0000-0001-7213-9464"]},"institutions":[{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lo\u00efc Renaud","raw_affiliation_strings":["Department of Blood Diseases, Centre Hospitalier Universit\u00e9 (CHU) de Lille, Lille, France;"],"raw_orcid":"https://orcid.org/0000-0001-7213-9464","affiliations":[{"raw_affiliation_string":"Department of Blood Diseases, Centre Hospitalier Universit\u00e9 (CHU) de Lille, Lille, France;","institution_ids":["https://openalex.org/I3018718406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083826444","display_name":"Damien Roos\u2010Weil","orcid":"https://orcid.org/0000-0002-7767-755X","observed_orcids":["https://orcid.org/0000-0002-7767-755X"]},"institutions":[{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210121705","display_name":"Piti\u00e9-Salp\u00eatri\u00e8re Hospital","ror":"https://ror.org/02mh9a093","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210121705"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Damien Roos-Weil","raw_affiliation_strings":["Service d\u2019H\u00e9matologie Clinique, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, AP-HP, Sorbonne Universit\u00e9, Paris, France;"],"raw_orcid":"https://orcid.org/0000-0002-7767-755X","affiliations":[{"raw_affiliation_string":"Service d\u2019H\u00e9matologie Clinique, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, AP-HP, Sorbonne Universit\u00e9, Paris, France;","institution_ids":["https://openalex.org/I39804081","https://openalex.org/I4210097159","https://openalex.org/I4210121705"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082685353","display_name":"C\u00e9dric Rossi","orcid":"https://orcid.org/0000-0003-3717-7961","observed_orcids":["https://orcid.org/0000-0003-3717-7961"]},"institutions":[{"id":"https://openalex.org/I4210116240","display_name":"CHU Dijon Bourgogne","ror":"https://ror.org/0377z4z10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210116240"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Cedric Rossi","raw_affiliation_strings":["Department of Hematology, CHU Dijon, Dijon, France;"],"raw_orcid":"https://orcid.org/0000-0003-3717-7961","affiliations":[{"raw_affiliation_string":"Department of Hematology, CHU Dijon, Dijon, France;","institution_ids":["https://openalex.org/I4210116240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027749653","display_name":"Eric Van Den Neste","orcid":"https://orcid.org/0000-0002-7846-4185","observed_orcids":["https://orcid.org/0000-0002-7846-4185"]},"institutions":[{"id":"https://openalex.org/I1315288073","display_name":"Cliniques Universitaires Saint-Luc","ror":"https://ror.org/03s4khd80","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I1315288073"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Eric Van Den Neste","raw_affiliation_strings":["Department of Hematology, Saint-Luc University Hospital, Brussels, Belgium;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Saint-Luc University Hospital, Brussels, Belgium;","institution_ids":["https://openalex.org/I1315288073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037206907","display_name":"C\u00e9cile Leyronnas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cecile Leyronnas","raw_affiliation_strings":["Institut Daniel Hollard, Grenoble, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Daniel Hollard, Grenoble, France;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083548630","display_name":"Fatiha Merabet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120341","display_name":"H\u00f4pital Andr\u00e9 Mignot","ror":"https://ror.org/02r29r389","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210120341"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fatiha Merabet","raw_affiliation_strings":["Department of Hematology and Oncology, H\u00f4pital Andr\u00e9 Mignot, Le Chesnay, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, H\u00f4pital Andr\u00e9 Mignot, Le Chesnay, France;","institution_ids":["https://openalex.org/I4210120341"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108797145","display_name":"Jean\u2010Val\u00e8re Malfuson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136310","display_name":"H\u00f4pital d'instruction des Arm\u00e9es Percy","ror":"https://ror.org/039c2j878","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210136310"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean Val\u00e8re Malfuson","raw_affiliation_strings":["Department of Hematology, H\u00f4pital Percy, Clamart, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, H\u00f4pital Percy, Clamart, France;","institution_ids":["https://openalex.org/I4210136310"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110460549","display_name":"Mourad Tiab","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mourad Tiab","raw_affiliation_strings":["University Hospital, La Roche-sur-Yon, France; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital, La Roche-sur-Yon, France; and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013649293","display_name":"Lo\u00efc Ysebaert","orcid":"https://orcid.org/0000-0003-4102-7261","observed_orcids":["https://orcid.org/0000-0003-4102-7261","https://orcid.org/0000-0001-8478-5623"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lo\u00efc Ysebaert","raw_affiliation_strings":["Service d\u2019H\u00e9matologie, Institut Universitaire du Cancer Toulouse-Oncop\u00f4le, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service d\u2019H\u00e9matologie, Institut Universitaire du Cancer Toulouse-Oncop\u00f4le, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110647265","display_name":"Samuel Y. Ng","orcid":"https://orcid.org/0000-0003-1140-0627","observed_orcids":["https://orcid.org/0000-0003-1140-0627"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samuel Ng","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051605599","display_name":"Franck Morschhauser","orcid":"https://orcid.org/0000-0002-3714-9824","observed_orcids":["https://orcid.org/0000-0002-3714-9824"]},"institutions":[{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Franck Morschhauser","raw_affiliation_strings":["Department of Blood Diseases, Centre Hospitalier Universit\u00e9 (CHU) de Lille, Lille, France;"],"raw_orcid":"https://orcid.org/0000-0002-3714-9824","affiliations":[{"raw_affiliation_string":"Department of Blood Diseases, Centre Hospitalier Universit\u00e9 (CHU) de Lille, Lille, France;","institution_ids":["https://openalex.org/I3018718406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027978059","display_name":"Philipp Bernhard Staber","orcid":"https://orcid.org/0000-0001-6729-7708","observed_orcids":["https://orcid.org/0000-0001-6729-7708"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":true,"raw_author_name":"Philipp B. Staber","raw_affiliation_strings":["Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria;","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063755644","display_name":"Matthew Steven Davids","orcid":"https://orcid.org/0000-0003-4529-2003","observed_orcids":["https://orcid.org/0000-0003-4529-2003"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Matthew S. Davids","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":"https://orcid.org/0000-0003-4529-2003","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":21,"corresponding_author_ids":["https://openalex.org/A5009837774","https://openalex.org/A5012731491","https://openalex.org/A5027978059","https://openalex.org/A5045486705","https://openalex.org/A5063755644"],"corresponding_institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I3018718406","https://openalex.org/I4210117453","https://openalex.org/I4387152542","https://openalex.org/I76134821"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":4.6954,"has_fulltext":false,"cited_by_count":41,"citation_normalized_percentile":{"value":0.96044552,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"137","issue":"25","first_page":"3495","last_page":"3506"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.8970000147819519,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.8970000147819519,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.05220000073313713,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.026399999856948853,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/t-cell-prolymphocytic-leukemia","display_name":"T-cell prolymphocytic leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9660000205039978},{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/belinostat","display_name":"belinostat","score":0.8180000185966492},{"id":"https://openalex.org/keywords/bh3-profiling","display_name":"BH3 profiling","score":0.9079999923706055},{"id":"https://openalex.org/keywords/bcl-2-dependence","display_name":"BCL-2 dependence","score":0.824999988079071},{"id":"https://openalex.org/keywords/jak-stat-inhibition","display_name":"JAK/STAT inhibition","score":0.7870000004768372},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.8700000047683716},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.859000027179718},{"id":"https://openalex.org/keywords/jak3-mutations","display_name":"JAK3 mutations","score":0.8980000019073486},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5239999890327454},{"id":"https://openalex.org/keywords/refractory-leukemia","display_name":"refractory leukemia","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.8710869550704956},{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.7523666620254517},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5509412288665771},{"id":"https://openalex.org/C2775983024","wikidata":"https://www.wikidata.org/wiki/Q2112719","display_name":"Prolymphocytic leukemia","level":4,"score":0.5005698204040527},{"id":"https://openalex.org/C2781462825","wikidata":"https://www.wikidata.org/wiki/Q7363205","display_name":"Romidepsin","level":5,"score":0.4693252444267273},{"id":"https://openalex.org/C2779015954","wikidata":"https://www.wikidata.org/wiki/Q420164","display_name":"Alemtuzumab","level":3,"score":0.4328805208206177},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42269501090049744},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.35463887453079224},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.3373996615409851},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31021687388420105},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26118260622024536},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2579349875450134},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.23253032565116882},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.20421570539474487},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.14213919639587402},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.13041377067565918},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.07110768556594849},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015461","descriptor_name":"Leukemia, Prolymphocytic, T-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015461","descriptor_name":"Leukemia, Prolymphocytic, T-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015461","descriptor_name":"Leukemia, Prolymphocytic, T-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020935","descriptor_name":"MAP Kinase Signaling System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1182/blood.2020007303","doi":"https://doi.org/10.1182/blood.2020007303","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.2020007303","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:33598678","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33598678","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Clinical Trial"},{"id":"pmh:oai:HAL:hal-03440992v1","doi":null,"is_oa":false,"landing_page_url":"https://uca.hal.science/hal-03440992","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood, 2021, 137 (25), pp.3495-3506. ⟨10.1182/blood.2020007303⟩","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dial.uclouvain.be:boreal:261896","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2078.1/261896","pdf_url":null,"source":{"id":"https://openalex.org/S4306401902","display_name":"Digital Access to Libraries (Universit\u00e9 catholique de Louvain (UCL), l'Universit\u00e9 de Namur (UNamur) and the Universit\u00e9 Saint-Louis (USL-B))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I95674353","host_organization_name":"UCLouvain","host_organization_lineage":["https://openalex.org/I95674353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood, Vol. 137, no.25, p. 3495-3506 (2021)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dial.uclouvain.be:boreal:264153","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2078.1/264153","pdf_url":null,"source":{"id":"https://openalex.org/S4306400166","display_name":"Digital Access to Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2800384882","host_organization_name":"Harris County Public Library","host_organization_lineage":["https://openalex.org/I2800384882"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood, Vol. 137, no.25, p. 3495-3506 (2021)","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:dial.uclouvain.be:boreal:261896","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2078.1/261896","pdf_url":null,"source":{"id":"https://openalex.org/S4306401902","display_name":"Digital Access to Libraries (Universit\u00e9 catholique de Louvain (UCL), l'Universit\u00e9 de Namur (UNamur) and the Universit\u00e9 Saint-Louis (USL-B))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I95674353","host_organization_name":"UCLouvain","host_organization_lineage":["https://openalex.org/I95674353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood, Vol. 137, no.25, p. 3495-3506 (2021)","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1558462233","https://openalex.org/W1913005460","https://openalex.org/W1977198374","https://openalex.org/W1998467884","https://openalex.org/W2009593167","https://openalex.org/W2047115666","https://openalex.org/W2094111973","https://openalex.org/W2094642095","https://openalex.org/W2097290512","https://openalex.org/W2101731564","https://openalex.org/W2107773259","https://openalex.org/W2113011422","https://openalex.org/W2118953824","https://openalex.org/W2124345149","https://openalex.org/W2152434002","https://openalex.org/W2165056381","https://openalex.org/W2168799171","https://openalex.org/W2580821712","https://openalex.org/W2745346554","https://openalex.org/W2763652944","https://openalex.org/W2794971923","https://openalex.org/W2808653175","https://openalex.org/W2894848403","https://openalex.org/W2908948881","https://openalex.org/W2909786297","https://openalex.org/W2937210925","https://openalex.org/W2961584900","https://openalex.org/W2963029329","https://openalex.org/W2990697662","https://openalex.org/W3004547934","https://openalex.org/W3005150350","https://openalex.org/W3007751495"],"related_works":["https://openalex.org/W2989833240","https://openalex.org/W4393924428","https://openalex.org/W3213857660","https://openalex.org/W2987417079","https://openalex.org/W4389248716","https://openalex.org/W2952024170","https://openalex.org/W3132531164","https://openalex.org/W2763652944","https://openalex.org/W4415940329","https://openalex.org/W3004547934"],"abstract_inverted_index":{"Conventional":[0],"therapies":[1],"for":[2,125,135,228],"patients":[3,80,186],"with":[4,81,155,162,187,190],"T-cell":[5,37],"prolymphocytic":[6],"leukemia":[7],"(T-PLL),":[8],"such":[9,235],"as":[10,40,42,224],"cytotoxic":[11],"chemotherapy":[12],"and":[13,18,36,104,127,132,195,205,220],"alemtuzumab,":[14],"have":[15,25],"limited":[16],"efficacy":[17],"considerable":[19],"toxicity.":[20],"Several":[21],"novel":[22,71],"agent":[23],"classes":[24],"demonstrated":[26],"preclinical":[27],"activity":[28,56],"in":[29,57,66,74,147,202,237],"T-PLL,":[30],"including":[31],"inhibitors":[32,217],"of":[33,97,108,123,140,193,208,218,234],"the":[34,48,95,105,152,156,209,221],"JAK/STAT":[35,153,222],"receptor":[38],"pathways,":[39],"well":[41],"histone":[43],"deacetylase":[44],"(HDAC)":[45],"inhibitors.":[46],"Recently,":[47],"BCL-2":[49,131,141,169],"inhibitor":[50,158],"venetoclax":[51,194],"also":[52],"showed":[53],"some":[54],"clinical":[55,232],"T-PLL.":[58,238],"We":[59,197],"sought":[60],"to":[61,68,93,100,177],"characterize":[62],"functional":[63,91],"apoptotic":[64],"dependencies":[65],"T-PLL":[67,83,116,149,175,189,204],"identify":[69],"a":[70,90,98,109,119,191,199,206,231],"combination":[72,192,226],"therapy":[73],"this":[75],"disease.":[76,211],"Twenty-four":[77],"samples":[78],"from":[79],"primary":[82,148],"were":[84],"studied":[85],"by":[86],"using":[87],"BH3":[88],"profiling,":[89],"assay":[92],"assess":[94],"propensity":[96],"cell":[99,110,145],"undergo":[101],"apoptosis":[102,126],"(priming)":[103],"relative":[106],"dependence":[107,167],"on":[111,130,168,180],"different":[112],"antiapoptotic":[113],"proteins.":[114],"Primary":[115],"cells":[117,176],"had":[118],"relatively":[120],"low":[121],"level":[122],"priming":[124],"predominantly":[128],"depended":[129],"MCL-1":[133,143],"proteins":[134],"survival.":[136],"Selective":[137],"pharmacologic":[138],"inhibition":[139],"or":[142,160],"induced":[144],"death":[146],"cells.":[150],"Targeting":[151],"pathway":[154,223],"JAK1/2":[157],"ruxolitinib":[159],"HDAC":[161,219],"belinostat":[163],"both":[164],"independently":[165],"increased":[166],"but":[170],"not":[171],"MCL-1,":[172],"thereby":[173],"sensitizing":[174],"venetoclax.":[178],"Based":[179],"these":[181],"results,":[182],"we":[183],"treated":[184],"2":[185],"refractory":[188],"ruxolitinib.":[196],"observed":[198],"deep":[200],"response":[201],"JAK3-mutated":[203],"stabilization":[207],"nonmutated":[210],"Our":[212],"functional,":[213],"precision-medicine-based":[214],"approach":[215],"identified":[216],"promising":[225],"partners":[227],"venetoclax,":[229],"warranting":[230],"exploration":[233],"combinations":[236]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":7}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2021-03-01T00:00:00"}